Clinical Considerations of Drug-Induced Hepatotoxicity

Comprehensive Toxicology, Second Edition

Volumn 9, Issue , 2010, Pages 369-381

  Jain, S ^a   Kaplowitz, N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012847538     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-046884-6.01014-9     Document Type: Chapter

References (44)

1. Abboud G., Kaplowitz N. Drug Saf. 2007, 30:277-294.
2. Acuna G., Foernzler D., Leong D., Rabbia N., Smit R., Dorflinger E., Gasser R., Hoh J., Ott J., Borroni E., et al. Pharmacogenomics J. 2002, 2:327-334.
3. Aithal G.P., Ramsay L., Daly A.K., Sonchit N., Leathart J.B.S., Alexander G., Kenna J.G., Caldwell J., Day C.P. Hepatology 2004, 39:1430-1440.
4. Alla V., Abraham J., Siddiqui J., Raina D., Wu G.Y., Chalasani N.P., Bonkovsky H.L. J. Clin. Gastroenterol. 2006, 40(8):757-761.
5. Andrade R.J., Lucena M.I., Alonso A., García-Cortes M., García-Ruiz E., Benitez R., Fernández M.C., Pelaez G., Romero M., Corpas R., et al. Hepatology 2004, 39:1603-1612.
6. Andrade R.J., Lucena M.I., Fernández M.C., Pelaez G., Pachkoria K., García-Ruiz E., García-Muñoz B., González-Grande R., Pizarro A., Durán J.A., et al. Gastroenterology 2005, 129:512-521.
7. Benichou C. J. Hepatol. 1990, 11:272-276.
8. Bjornsson E., Olsson R. Hepatology 2005, 42:481-489.
9. Bohan T.P., Helton E., McDonald I., König S., Gazitt S., Sugimoto T., Scheffner D., Cusmano L., Li S., Koch G. Neurology 2001, 56:1405-1409.
10. 1979, National Institute of Health, Washington, DC. C.S. Davidson, C.M. Leevy, E.C. Chamberlayne (Eds.).
11. Fountain F.F., Tolley E., Chrisman C.R., Self T.H. Chest 2005, 128:116-123.
12. Freston, J. Use and limitations of the RUCAM, AASLD-FDA-NIH-PhRMA Hepatotoxcity Steering Group Meeting, 2006 presentation.
13. Graham D.J., Green L., Senior J.R., Nourjah P. Am. J. Med. 2003, 114:299-306.
14. Gunawan B., Kaplowitz N. Drug Metab. Rev. 2004, 36:301-312.
15. Helmy A. Aliment. Pharmacol. Ther. 2006, 23(1):11-25.
16. Hoofnagle J.H., Carithers R.L., Shapiro C., Ascher N. Hepatology 1995, 21:240-252.
17. Huang Y.S., Chern H.D., Su W.J., Wu J.C., Chang S.C., Chiang C.H., Chang F.Y., Lee S.D. Hepatology 2003, 37:924-930.
18. Kaplowitz N. J. Hepatol. 2000, 32:39-47.
19. Kaplowitz N. Clin. Infect. Dis. 2004, 38:S44-S48.
20. Kaplowitz N. Nat. Rev. Drug Discov. 2005, 4:489-499.
21. Kaplowitz N. Pharmacoepidemiol. Drug Saf. 2006, 15:231-233.
22. Kaplowitz, N.; DeLeve, L., Eds.; In Drug-Induced Liver Disease, 1st ed.; Marcel Dekker: New York, 2002.
23. Klein A.S., Hart J., Brems J.J., Goldstein L., Lewin K., Busuttil R.W. Am. J. Med. 1989, 86:187-193.
24. Lee W. N. Engl. J. Med. 2003, 349(5):474-485.
25. Lee W.M. Liver Diseases: Mechanisms of Liver Injury in Emerging Therapeutics 2006, John B. Hynes Veterans Memorial Convention Center, Boston, MA, AASLD Postgraduate Course 2006.
26. Leist M., Single B., Castoldi A.F., Kühnle S., Nicotera P. J. Exp. Med. 1997, 185:1481-1486.
27. Liu Z.X., Kaplowitz N. Clin. Liver Dis. 2002, 6(3):755-774.
28. Loeper J., Descatoire V., Maurice M., Beaune P., Feldmann G., Larrey D., Pessayre D. Hepatology 1990, 11:850-858.
29. Lucena M.I., García-Cortés M., Cueto R., Lopez-Duran J., Andrade R.J. Fundam. Clin. Pharmacol. 2008, 22(2):141-158.
30. Maddrey W.C. J. Clin. Gastroenterol. 2005, 39:S83-S89.
31. Nathwani R., Kaplowitz N. Clin. Liver Dis. 2006, 10:207-217.
32. Navarro, V. Hepatic Adverse Event Nomenclature Document [online]. Accessed on 17 November 2006 available from . http://www.fda.gov/cder/livertox/presentations2005/Vic_Navarro.ppt.
33. Navarro V.J., Senior J.R. N. Engl. J. Med. 2006, 354(7):731-739.
34. Ostapowicz G.A., Fontana R.J., Schiødt F.V., Larson A., Davern T.J., Han S.H., McCashland T.M., Shakil A.O., Hay J.E., Hynan L., et al. Ann. Intern. Med. 2002, 137:947-954.
35. Pelli N., Setti M. J. Hepatol. 2004, 40(4):716.
36. Polson J., Lee W.M. Hepatology 2005, 1179-1197.
37. Rakela J., Mosley J.W., Edwards V.M., Govindarajan S., Alpert E. Dig. Dis. Sci. 1991, 36:1223-1228.
38. Rengstorff D.S., Osorio R.W., Bonacini M. Clin. Gastroenterol. Hepatol. 2003, 1:392-396.
39. Simon T., Becquemont L., Mary-Krause M., de Waziers I., Beaune P., Funck-Brentano C., Jaillon P. Clin. Pharmacol. Ther. 2000, 67:432-437.
40. Spagnuolo M.I., Iorio R., Vegnente A., Guarino A. Gastroenterology 1996, 111:716-719.
41. Watanabe I., Tomita A., Shimizu M., Sugawara M., Yasumo H., Koishi R., Takahashi T., Miyoshi K., Nakamura K., Izumi T., et al. Clin. Pharmacol. Ther. 2003, 73:435-455.
42. Watkins P.B., Zimmerman H.J., Knapp M.J., Gracon S.I., Lewis K.W. JAMA 1994, 271:992-998.
43. Zhang W.V., Ramzan I., Murray M. J. Pharmacol. Exp. Ther. 2007, 322:770-777.
44. Zimmerman H. Schiff's Diseases of the Liver 1999, 973-1064. Lippincott-Raven Publishers, Baltimore, MD. E. Schiff (Ed.).